<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04645823</url>
  </required_header>
  <id_info>
    <org_study_id>Versio4_22112020</org_study_id>
    <secondary_id>2020-005506-26</secondary_id>
    <nct_id>NCT04645823</nct_id>
  </id_info>
  <brief_title>Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor</brief_title>
  <official_title>Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Women's Hospital HUS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Women's Hospital HUS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A total of 60 parturients undergoing induction of labour will be consented to participate in&#xD;
      the study where they will be randomized to receive either spinal fentanyl (20 µg) or epidural&#xD;
      analgesia (fentanyl 100µg and lidocaine 80 mg).&#xD;
&#xD;
      They will be monitored for the development of analgesia for a duration of 30 minutes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 26, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>60 parturients randomized to two different treatment arms (30 in each group)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The parturient and the midwife as well as the researcher doing the interview for analgesia will be masked. The anesthesiologist performing either spinal fentanyl administration or epidural analgesia will not be masked</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia at 20 minutes</measure>
    <time_frame>20 minutes</time_frame>
    <description>Reduction of visual analog scale (VAS) pain during contraction from pre-intervention value. 0 mm means no pain while 100 mm means worst possible pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time until pain returns to 60 mm VAS</measure>
    <time_frame>30-180 minutes</time_frame>
    <description>Time from intervention until the maximum pain during contraction return to 60 mm on VAS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ambulation during the analgesia provided by the intervention</measure>
    <time_frame>30-180 minutes</time_frame>
    <description>HAs the parturient been walking during the analgesia provided by the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the cardiotocography (fetal heart rate) within 30 minutes after the intervention</measure>
    <time_frame>0-30 minutes</time_frame>
    <description>Graded as none, moderate, severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritus</measure>
    <time_frame>0-30 minutes</time_frame>
    <description>The incidence of pruritus within 30 minutes after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAtisfaction of the parturient with the analgesia provided by the intervention</measure>
    <time_frame>at 30 minutes</time_frame>
    <description>On 0-100 mm visual analog scale (VAS). Where 0 means no satisfaction at all and 100 mm means maximum satisfaction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Labor Pain</condition>
  <condition>Induced; Birth</condition>
  <arm_group>
    <arm_group_label>Spinal fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Using a combined spinal epidural technique a single dose of 20 µg of fentanyl diluted into 2 ml with NaCl 0.9 % will be injected into the CSF at lower lumbar interspace. An epidural catheter is left in place for subsequent analgesic doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural lidocaine and fentanyl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using a catheter in the epidural space in the lower lumbar interspace a single dose of lidocaine (80 mg) and fentanyl (100 µg) is given. The epidural catheter is left in place for subsequent analgesic doses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl Citrate</intervention_name>
    <description>Fentanyl citrate 20 µg in 2 ml of saline injected into csf</description>
    <arm_group_label>Spinal fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1% Injectable Solution</intervention_name>
    <description>Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume</description>
    <arm_group_label>Epidural lidocaine and fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl Citrate</intervention_name>
    <description>Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume</description>
    <arm_group_label>Epidural lidocaine and fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Signs a consent form to participate voluntarily into the trial&#xD;
&#xD;
          2. Induced labor&#xD;
&#xD;
          3. singleton pregnancy&#xD;
&#xD;
          4. primiparous&#xD;
&#xD;
          5. BMI 20-40 at the time of delivery&#xD;
&#xD;
          6. No history of allergy for lidocaine or fentanyl&#xD;
&#xD;
          7. sufficient command of Finnish language to understand the consent form and interview&#xD;
&#xD;
          8. Cervical dilatation at maximum 4 cm at the time of intervention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any contraindication for spinal or epidural analgesia&#xD;
&#xD;
          2. Allergy for lidocaine or fentanyl&#xD;
&#xD;
          3. The patient has received any opioid medication within 90 minutes prior to intervention&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>All recruited patients are parturients undergoing induction of labor</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antti J Vaananen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HUCH, Women's hospital/dept of anesthesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HUS/Women's hospital dept of anaesthesia</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 22, 2020</study_first_submitted>
  <study_first_submitted_qc>November 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2020</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Women's Hospital HUS</investigator_affiliation>
    <investigator_full_name>Antti Vaananen</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>epidural analgesia</keyword>
  <keyword>spinal analgesia</keyword>
  <keyword>labor pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Sodium Citrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

